Insider · CIK 0001947086
Anne Altmeyer
Files at CRBP (Corbus Pharmaceuticals Holdings, Inc.). First filing Jun 2, 2025, latest Oct 21, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRBP: Corbus Pharmaceuticals Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Corbus Pharmaceuticals Holdings, Inc. | $22k 1,060 shares | -15% | +272% from low-5% from high | |
| 23Weak | Corbus Pharmaceuticals Holdings, Inc. | $10k 1,392 shares | -50% | +51% from low-87% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | MOption exercise Common Stock, par value $0.0001 per share10b5-1 | +1,060 | $4.80 | $5,088 | 7,251 | Oct 21, 2025 |
| Oct 20, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stock, par value $0.0001 per share10b5-1 | -1,060 | $20.50 | $22k | 6,191 | Oct 21, 2025 |
| Oct 20, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | MOption exercise Stock options (right to buy)derivative10b5-1 | -1,060 | $0.00 | $0 | 4,247 | Oct 21, 2025 |
| May 30, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | SOpen-market sale Common Stock, par value $0.0001 per share10b5-1 | -1,392 | $7.25 | $10k | 1,391 | Jun 2, 2025 |
| May 30, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share10b5-1 | +4,800 | $0.00 | $0 | 6,191 | Jun 2, 2025 |
| May 30, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | AGrant or award Stock options (right to buy)derivative10b5-1 | +16,000 | $0.00 | $0 | 16,000 | Jun 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.